Published in Stem Cells on May 15, 2015
Impact of the physical microenvironment on tumor progression and metastasis. Curr Opin Biotechnol (2016) 0.89
Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis. Ann Transl Med (2015) 0.86
MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway. Oncotarget (2015) 0.84
Cisplatin induces stemness in ovarian cancer. Oncotarget (2016) 0.83
Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells. Stem Cell Reports (2017) 0.78
NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Discov (2016) 0.77
Stress granule-associated protein G3BP2 regulates breast tumor initiation. Proc Natl Acad Sci U S A (2017) 0.75
Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation. Curr Stem Cell Rep (2016) 0.75
Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism. Cancer Lett (2016) 0.75
Increased cancer stem cell invasion is mediated by myosin IIB and nuclear translocation. Oncotarget (2016) 0.75
eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Cancer Res (2017) 0.75
Overview of Cancer Stem Cells and Stemness for Community Oncologists. Target Oncol (2017) 0.75
STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance. Endocr Relat Cancer (2017) 0.75
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors. J Exp Med (2017) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res (2007) 16.79
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst (2008) 11.93
Triple-negative breast cancer. N Engl J Med (2010) 11.39
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst (2006) 10.06
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res (2009) 7.98
Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell (2009) 7.09
Prognostic markers in triple-negative breast cancer. Cancer (2007) 6.28
Tumour heterogeneity and cancer cell plasticity. Nature (2013) 5.47
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res (2009) 4.47
Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res (2005) 4.33
Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol (2007) 3.93
Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell (2010) 3.82
Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A (2010) 2.89
Dissecting the heterogeneity of triple-negative breast cancer. J Clin Oncol (2012) 2.64
Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (2009) 2.59
Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev (2009) 2.40
NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene (2011) 2.22
Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer (2008) 2.11
Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell (2014) 1.99
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J (2012) 1.86
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells. Proc Natl Acad Sci U S A (2011) 1.68
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents. Ann Oncol (2012) 1.64
CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. Cancer Res (2010) 1.52
CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Hum Pathol (2011) 1.52
miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene (2010) 1.51
Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol (2009) 1.43
The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures. Breast Cancer Res Treat (2010) 1.36
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance. Breast Cancer Res (2011) 1.29
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer. Histopathology (2011) 1.22
Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res (2011) 1.15
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol (2012) 1.14
JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer (2009) 1.13
Prognostic significance of NANOG and KLF4 for breast cancer. Breast Cancer (2012) 1.13
Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocr Relat Cancer (2013) 1.06
Optimizing chemotherapy-free survival for the ER/HER2-positive metastatic breast cancer patient. Clin Cancer Res (2011) 1.01
High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor. Cell Rep (2013) 0.99
Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity. Oncotarget (2013) 0.97
A flexible reporter system for direct observation and isolation of cancer stem cells. Stem Cell Reports (2014) 0.91
In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. Cell Cycle (2013) 0.89
Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. PLoS One (2011) 0.86
A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibody. Int J Cancer (2012) 0.86
Junctional adhesion molecules in angiogenesis. Front Biosci (2008) 0.83
Putting the brakes on cancer cell migration: JAM-A restrains integrin activation. Cell Adh Migr (2008) 0.83
Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes. Virchows Arch (2012) 0.82
Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell lines. PLoS One (2013) 0.81
Expression of cancer stem cell markers in basal and penta-negative breast carcinomas--a study of a series of triple-negative tumors. Pathol Res Pract (2014) 0.81
Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression. Cell Stem Cell (2016) 1.52
Differential connexin function enhances self-renewal in glioblastoma. Cell Rep (2015) 0.91